Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine Read more about Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine
The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination Read more about The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination
Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis Read more about Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above Read more about Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above
Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China Read more about Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China
This Study Investigate the Impact of Maternal COVID-19 Infection During Birth on the Childrens' Physical and Mental Development. Read more about This Study Investigate the Impact of Maternal COVID-19 Infection During Birth on the Childrens' Physical and Mental Development.
Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection Read more about Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection
A Study on Children With COVID-19 Admitted at Assiut University Children Hospital Read more about A Study on Children With COVID-19 Admitted at Assiut University Children Hospital
Comprehensive Imaging Exam of Convalesced COVID-19 Patients Read more about Comprehensive Imaging Exam of Convalesced COVID-19 Patients
Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years Read more about Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years
